[Form 4] ProMIS Neurosciences Inc. Insider Trading Activity
On 03/13/2025 Michael S. Gordon reported changes in his beneficial ownership of ProMIS Neurosciences Inc. (PMN). The Form 4 shows a disposition of 48,333 common shares under Code J, and identifies indirect holdings of 2,435,029 shares through "Promis" and previously through "Title 19 Acies." The filing explains that Title 19 Aciess ownership was assigned to Skye Peak Partners LLC effective 01/01/2025 and management of that entity changed, removing Gordons investment control over those shares.
The Form notes that, based on the issuer's later filing showing 51,806,497 shares outstanding, Gordons ownership fell below 10% as of this Form 4 filing date; it also states Gordon held more than 10% when the Form 4 was originally due. The Form is signed 08/14/2025 and contains an explanatory remark about timing and ownership calculations.
Il 13/03/2025 Michael S. Gordon ha comunicato modifiche nella sua partecipazione in ProMIS Neurosciences Inc. (PMN). Il Modulo 4 riporta la cessione di 48.333 azioni ordinarie ai sensi del Codice J e indica una detenzione indiretta di 2.435.029 azioni tramite "Promis" e, in precedenza, tramite "Title 19 Acies". La segnalazione spiega che la propriet脿 di Title 19 Acies 猫 stata trasferita a Skye Peak Partners LLC con efficacia 01/01/2025 e che la gestione di tale entit脿 猫 cambiata, privando Gordon del controllo degli investimenti su quelle azioni.
Il Modulo rileva inoltre che, sulla base di una successiva comunicazione dell'emittente che indica 51.806.497 azioni in circolazione, la partecipazione di Gordon 猫 scesa sotto il 10% alla data di presentazione del presente Modulo 4; si precisa anche che Gordon deteneva oltre il 10% quando il Modulo 4 era originariamente dovuto. Il Modulo 猫 firmato il 14/08/2025 e contiene una nota esplicativa sui calcoli e sui tempi relativi alla propriet脿.
El 13/03/2025 Michael S. Gordon inform贸 cambios en su participaci贸n beneficiaria de ProMIS Neurosciences Inc. (PMN). El Formulario 4 muestra una disposici贸n de 48.333 acciones ordinarias bajo el C贸digo J e identifica tenencias indirectas de 2.435.029 acciones a trav茅s de "Promis" y anteriormente mediante "Title 19 Acies". La presentaci贸n explica que la titularidad de Title 19 Acies fue asignada a Skye Peak Partners LLC con efecto 01/01/2025 y que la gesti贸n de esa entidad cambi贸, eliminando el control de inversi贸n de Gordon sobre esas acciones.
El Formulario se帽ala adem谩s que, bas谩ndose en una presentaci贸n posterior del emisor que muestra 51.806.497 acciones en circulaci贸n, la participaci贸n de Gordon cay贸 por debajo del 10% en la fecha de presentaci贸n de este Formulario 4; tambi茅n indica que Gordon pose铆a m谩s del 10% cuando el Formulario 4 deb铆a haberse presentado originalmente. El Formulario est谩 firmado el 14/08/2025 y contiene una anotaci贸n explicativa sobre el momento y los c谩lculos de propiedad.
2025雲� 3鞗� 13鞚� Michael S. Gordon鞚� ProMIS Neurosciences Inc.(PMN)鞐� 雽�頃� 鞁れ唽鞙� 氤�霃欖潉 鞁犼碃頄堨姷雼堧嫟. Form 4電� 旖旊摐 J鞐� 霐半ジ 氤错喌欤� 48,333欤检潣 觳橂秳鞚� 旮办灛頃橁碃, "Promis"毳� 韱淀暣 攴鸽Μ瓿� 鞚挫爠鞐愲姅 "Title 19 Acies"毳� 韱淀暣 臧勳爲 氤挫湢頃� 2,435,029欤茧ゼ 鞁濍硠頃╇媹雼�. 鞁犼碃靹滊姅 Title 19 Acies鞚� 靻岇湢甓岇澊 2025雲� 1鞗� 1鞚茧秬搿� Skye Peak Partners LLC鞐� 鞏戨弰霅橃棃鞙茧┌ 頃措嫻 氩曥澑鞚� 甏�毽皜 氤�瓴诫悩鞏� Gordon鞚� 韴瀽 韱奠牅甓岇澊 頃措嫻 欤检嫕鞐愳劀 鞝滉卑霅橃棃鞚岇潉 靹る獏頃╇媹雼�.
霕愴暅 Form鞚� 氚滍枆鞚胳澊 鞚错泟 鞝滌稖頃� 靹滊鞐愳劀 鞙犿喌 欤检嫕 靾橁皜 51,806,497欤茧 響滌嫓霅� 瓴冹潉 攴缄卑搿�, 鞚� Form 4 鞝滌稖鞚� 旮办 Gordon鞚� 氤挫湢鞙澊 10% 氙鸽鞙茧 霒柎臁岇潓鞚� 旮半頃橁碃 鞛堨溂氅�; 鞗愲灅 Form 4 鞝滌稖 旮绊暅鞐愲姅 Gordon鞚� 10%毳� 齑堦臣 氤挫湢頃橁碃 鞛堨棃雼り碃 氇呾嫓頃╇媹雼�. 頃措嫻 Form鞚� 2025雲� 8鞗� 14鞚检棎 靹滊獏霅橃棃瓿� 靻岇湢甓� 瓿勳偘 氚� 鞁滌爯鞐� 甏�頃� 靹る獏鞚� 韽暔霅橃柎 鞛堨姷雼堧嫟.
Le 13/03/2025, Michael S. Gordon a signal茅 des modifications de sa d茅tention effective de ProMIS Neurosciences Inc. (PMN). Le formulaire 4 indique une cession de 48 333 actions ordinaires en vertu du code J et identifie une d茅tention indirecte de 2 435 029 actions via "Promis" et auparavant via "Title 19 Acies". Le d茅p么t pr茅cise que la propri茅t茅 de Title 19 Acies a 茅t茅 transf茅r茅e 脿 Skye Peak Partners LLC 脿 compter du 01/01/2025 et que la gouvernance de cette entit茅 a chang茅, ce qui a retir茅 脿 Gordon le contr么le des investissements sur ces actions.
Le formulaire note 茅galement que, d'apr猫s une d茅claration ult茅rieure de l'茅metteur faisant 茅tat de 51 806 497 actions en circulation, la participation de Gordon est tomb茅e en dessous de 10 % 脿 la date de d茅p么t de ce formulaire 4 ; il indique aussi que Gordon d茅tenait plus de 10 % lorsque le formulaire 4 茅tait initialement exigible. Le formulaire est sign茅 le 14/08/2025 et contient une remarque explicative sur le calendrier et les calculs relatifs 脿 la d茅tention.
Am 13.03.2025 meldete Michael S. Gordon 脛nderungen seines wirtschaftlichen Eigentums an ProMIS Neurosciences Inc. (PMN). Das Formular 4 weist eine Ver盲u脽erung von 48.333 Stammaktien gem盲脽 Code J aus und benennt eine indirekte Beteiligung von 2.435.029 Aktien 眉ber "Promis" und zuvor 眉ber "Title 19 Acies". In der Einreichung wird erl盲utert, dass das Eigentum an Title 19 Acies mit Wirkung zum 01.01.2025 an Skye Peak Partners LLC 眉bertragen wurde und sich die Gesch盲ftsf眉hrung dieser Einheit ge盲ndert hat, wodurch Gordons Anlagesteuerung 眉ber diese Aktien entfiel.
Das Formular stellt ferner fest, dass Gordons Beteiligung auf Basis einer sp盲teren Meldung des Emittenten, die 51.806.497 ausgegebene Aktien ausweist, zum Zeitpunkt der Einreichung dieses Formulars 4 unter 10 % gefallen ist; es wird auch angegeben, dass Gordon 眉ber 10 % hielt, als das Formular 4 urspr眉nglich f盲llig war. Das Formular ist vom 14.08.2025 unterschrieben und enth盲lt einen erl盲uternden Hinweis zu Zeitpunkten und Berechnungen der Eigentumsverh盲ltnisse.
- Disclosure of reassignment and management changes for Title 19 Acies is transparent and explained in the filing
- Reported specific amounts: disposition of 48,333 common shares and indirect ownership of 2,435,029 shares via Promis
- Late filing: Form is signed 08/14/2025 and remarks indicate timing issues relative to when the Form 4 was due
- Ownership threshold uncertainty: filing notes ownership dropped below 10% based on a later outstanding-share count, implying potential prior period reporting complexity
Insights
TL;DR: Insider reported a modest sale and a reallocation of indirect holdings that reduced his reported ownership below 10%.
The 48,333-share disposition is small relative to the issuers stated outstanding shares (51.8 million), so the direct market impact of this single reported sale is likely limited. The more material element is the reassignment of Title 19 Acies to Skye Peak Partners LLC effective 01/01/2025 and the accompanying change in management and investment control, which legally removes Gordons pecuniary interest in those shares. The filing also discloses a timing/filing issue: Gordon asserts he exceeded 10% when the Form 4 was due but, using the issuers later outstanding share count, his ownership is below 10% at filing. For investors, this is a disclosure of changing indirect ownership and a late-filed Form 4 rather than a large open-market liquidation.
TL;DR: Governance change: transfer of management and loss of investment control over an entity holding PMN shares; disclosure timing is notable.
The assignment of Title 19 Acies to Skye Peak Partners LLC and replacement of Gordon as sole manager with two other managers alters the governance and control profile of the entity that held PMN shares. That change is explicitly stated to remove Gordons pecuniary interest in those shares. The remarks indicate ownership threshold calculations and a late-filed Form 4 (signed 08/14/2025), which is relevant for compliance review but not presented as a regulatory sanction or litigation. This filing should prompt internal review of reporting timeliness and confirm denominators used for ownership thresholds.
Il 13/03/2025 Michael S. Gordon ha comunicato modifiche nella sua partecipazione in ProMIS Neurosciences Inc. (PMN). Il Modulo 4 riporta la cessione di 48.333 azioni ordinarie ai sensi del Codice J e indica una detenzione indiretta di 2.435.029 azioni tramite "Promis" e, in precedenza, tramite "Title 19 Acies". La segnalazione spiega che la propriet脿 di Title 19 Acies 猫 stata trasferita a Skye Peak Partners LLC con efficacia 01/01/2025 e che la gestione di tale entit脿 猫 cambiata, privando Gordon del controllo degli investimenti su quelle azioni.
Il Modulo rileva inoltre che, sulla base di una successiva comunicazione dell'emittente che indica 51.806.497 azioni in circolazione, la partecipazione di Gordon 猫 scesa sotto il 10% alla data di presentazione del presente Modulo 4; si precisa anche che Gordon deteneva oltre il 10% quando il Modulo 4 era originariamente dovuto. Il Modulo 猫 firmato il 14/08/2025 e contiene una nota esplicativa sui calcoli e sui tempi relativi alla propriet脿.
El 13/03/2025 Michael S. Gordon inform贸 cambios en su participaci贸n beneficiaria de ProMIS Neurosciences Inc. (PMN). El Formulario 4 muestra una disposici贸n de 48.333 acciones ordinarias bajo el C贸digo J e identifica tenencias indirectas de 2.435.029 acciones a trav茅s de "Promis" y anteriormente mediante "Title 19 Acies". La presentaci贸n explica que la titularidad de Title 19 Acies fue asignada a Skye Peak Partners LLC con efecto 01/01/2025 y que la gesti贸n de esa entidad cambi贸, eliminando el control de inversi贸n de Gordon sobre esas acciones.
El Formulario se帽ala adem谩s que, bas谩ndose en una presentaci贸n posterior del emisor que muestra 51.806.497 acciones en circulaci贸n, la participaci贸n de Gordon cay贸 por debajo del 10% en la fecha de presentaci贸n de este Formulario 4; tambi茅n indica que Gordon pose铆a m谩s del 10% cuando el Formulario 4 deb铆a haberse presentado originalmente. El Formulario est谩 firmado el 14/08/2025 y contiene una anotaci贸n explicativa sobre el momento y los c谩lculos de propiedad.
2025雲� 3鞗� 13鞚� Michael S. Gordon鞚� ProMIS Neurosciences Inc.(PMN)鞐� 雽�頃� 鞁れ唽鞙� 氤�霃欖潉 鞁犼碃頄堨姷雼堧嫟. Form 4電� 旖旊摐 J鞐� 霐半ジ 氤错喌欤� 48,333欤检潣 觳橂秳鞚� 旮办灛頃橁碃, "Promis"毳� 韱淀暣 攴鸽Μ瓿� 鞚挫爠鞐愲姅 "Title 19 Acies"毳� 韱淀暣 臧勳爲 氤挫湢頃� 2,435,029欤茧ゼ 鞁濍硠頃╇媹雼�. 鞁犼碃靹滊姅 Title 19 Acies鞚� 靻岇湢甓岇澊 2025雲� 1鞗� 1鞚茧秬搿� Skye Peak Partners LLC鞐� 鞏戨弰霅橃棃鞙茧┌ 頃措嫻 氩曥澑鞚� 甏�毽皜 氤�瓴诫悩鞏� Gordon鞚� 韴瀽 韱奠牅甓岇澊 頃措嫻 欤检嫕鞐愳劀 鞝滉卑霅橃棃鞚岇潉 靹る獏頃╇媹雼�.
霕愴暅 Form鞚� 氚滍枆鞚胳澊 鞚错泟 鞝滌稖頃� 靹滊鞐愳劀 鞙犿喌 欤检嫕 靾橁皜 51,806,497欤茧 響滌嫓霅� 瓴冹潉 攴缄卑搿�, 鞚� Form 4 鞝滌稖鞚� 旮办 Gordon鞚� 氤挫湢鞙澊 10% 氙鸽鞙茧 霒柎臁岇潓鞚� 旮半頃橁碃 鞛堨溂氅�; 鞗愲灅 Form 4 鞝滌稖 旮绊暅鞐愲姅 Gordon鞚� 10%毳� 齑堦臣 氤挫湢頃橁碃 鞛堨棃雼り碃 氇呾嫓頃╇媹雼�. 頃措嫻 Form鞚� 2025雲� 8鞗� 14鞚检棎 靹滊獏霅橃棃瓿� 靻岇湢甓� 瓿勳偘 氚� 鞁滌爯鞐� 甏�頃� 靹る獏鞚� 韽暔霅橃柎 鞛堨姷雼堧嫟.
Le 13/03/2025, Michael S. Gordon a signal茅 des modifications de sa d茅tention effective de ProMIS Neurosciences Inc. (PMN). Le formulaire 4 indique une cession de 48 333 actions ordinaires en vertu du code J et identifie une d茅tention indirecte de 2 435 029 actions via "Promis" et auparavant via "Title 19 Acies". Le d茅p么t pr茅cise que la propri茅t茅 de Title 19 Acies a 茅t茅 transf茅r茅e 脿 Skye Peak Partners LLC 脿 compter du 01/01/2025 et que la gouvernance de cette entit茅 a chang茅, ce qui a retir茅 脿 Gordon le contr么le des investissements sur ces actions.
Le formulaire note 茅galement que, d'apr猫s une d茅claration ult茅rieure de l'茅metteur faisant 茅tat de 51 806 497 actions en circulation, la participation de Gordon est tomb茅e en dessous de 10 % 脿 la date de d茅p么t de ce formulaire 4 ; il indique aussi que Gordon d茅tenait plus de 10 % lorsque le formulaire 4 茅tait initialement exigible. Le formulaire est sign茅 le 14/08/2025 et contient une remarque explicative sur le calendrier et les calculs relatifs 脿 la d茅tention.
Am 13.03.2025 meldete Michael S. Gordon 脛nderungen seines wirtschaftlichen Eigentums an ProMIS Neurosciences Inc. (PMN). Das Formular 4 weist eine Ver盲u脽erung von 48.333 Stammaktien gem盲脽 Code J aus und benennt eine indirekte Beteiligung von 2.435.029 Aktien 眉ber "Promis" und zuvor 眉ber "Title 19 Acies". In der Einreichung wird erl盲utert, dass das Eigentum an Title 19 Acies mit Wirkung zum 01.01.2025 an Skye Peak Partners LLC 眉bertragen wurde und sich die Gesch盲ftsf眉hrung dieser Einheit ge盲ndert hat, wodurch Gordons Anlagesteuerung 眉ber diese Aktien entfiel.
Das Formular stellt ferner fest, dass Gordons Beteiligung auf Basis einer sp盲teren Meldung des Emittenten, die 51.806.497 ausgegebene Aktien ausweist, zum Zeitpunkt der Einreichung dieses Formulars 4 unter 10 % gefallen ist; es wird auch angegeben, dass Gordon 眉ber 10 % hielt, als das Formular 4 urspr眉nglich f盲llig war. Das Formular ist vom 14.08.2025 unterschrieben und enth盲lt einen erl盲uternden Hinweis zu Zeitpunkten und Berechnungen der Eigentumsverh盲ltnisse.
FAQ
What did Michael S. Gordon report on Form 4 for PMN?
Why did Gordons reported ownership fall below 10%?
What change occurred with Title 19 Acies?
When was the Form 4 signed?
Does the Form 4 indicate any derivative transactions?
